European Pharmaceutical Review

FEBRUARY 7, 2023

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023. of the MDR and Article 110.4

Packaging 117

Packaging 117

Pharmaceutical Technology

JUNE 25, 2025

The European Commission (EC) faces a March 2027 deadline to adopt several key implementing acts, which will lay out detailed rules for putting the regulation into practice. The regulation came into force in March 2025; however, it has not yet come into application, with this set to happen in March 2029.

Communication 52

Communication Hospitals Packaging Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Immunization 105

Immunization Packaging Labelling FDA 105

Viseven

JUNE 12, 2023

from 2022 to 2027. Main Potential of Pharma in the Asia-Pacific Region What role does the APAC region play in transforming today’s worldwide pharma market? This role is significant because the pharma market in APAC is increasing. According to one forecast, researchers anticipate that APAC pharma will grow 4.2% And it makes sense.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). A Strategy for the Sector 2023–2027.”

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

Pharmaceutical Technology

JULY 2, 2025

The merger, announced in April 2025 , will positively impact Merck’s financial position by contributing to revenues immediately, and is anticipated to be accretive to its earnings per share by 2027. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication FDA Hospitals 52

Pharmaceutical Technology

JULY 2, 2025

With the additional funds from Sanofi’s investment and current assets on hand, it anticipates sufficient funds to sustain its planned operations in 2027. How will RFK Jr’s American dream for vaccines play out? As of December 2024, the company reported cash reserves of $85.2m.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 1, 2025

Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 1, 2025

The expansion will be concluded by late 2027, with production capacity increasing from 104 batches annually at peak utilisation to more than 240 batches. The expansion will introduce a new laboratory and advanced machinery such as a new filling line, two large size lyophilisers, a capping machine and an external vial washer.

Communication 52

Communication Packaging Hospitals Insurance 52

Roots Analysis

JANUARY 27, 2025

Insights on Approved Subcutaneous Biologics Market Analysis Driven by the increased emphasis towards patient compliance and improved treatment outcome, the approved subcutaneous biologics market is anticipated to grow at an annualized growth rate of around 5%, till 2027.

Hospitals 40

Hospitals Packaging Compounding Immunization 40

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Primary Packaging material designers. Secondary packagers. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. The global pre-filled syringes market was valued at $1139.6

Packaging 52

Packaging FDA Documentation Vaccines 52

STAT

SEPTEMBER 12, 2024

This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. Sound familiar? Have a great day, everyone.

Packaging 55

Packaging Vaccines 55

pharmaphorum

FEBRUARY 3, 2022

reaching £915 billion by 2027. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9%

Compounding 52

Compounding Packaging Vaccines 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

STAT

MAY 5, 2025

LONDON — The European Commission on Monday unveiled a roughly $565 million package to retain and attract scientists, as other countries try to leverage the Trump administration’s dismantling of research programs in the U.S. to build up their own enterprises.  Continue to STAT+ to read the full story…

Packaging 126

Packaging 126

BuzzRx

AUGUST 30, 2022

This law includes a broad package of provisions concerning healthcare, taxes, and climate change. The Trump Administration’s drug rebate rule will be delayed until 2032 The Inflation Reduction Act includes a provision to delay the implementation of the Trump administration’s drug rebate rule from 2027 to 2032.

Vaccines 52

Vaccines Insurance Packaging Immunization 52